The invention is directed to a pharmaceutical composition of topiramate, an anticonvulsant which is useful for treating epilepsy. More specifically, the present invention provides a solid dosage formulation of topiramate intended primarily for use by pediatric patients, or for patients who have difficulty swallowing tablets. Processes for preparing the pharmaceutical composition are also described.
CROSS-REFERENCE TO RELATED APPLICATION
This application is a divisional of U.S. application Ser. No. 09/259,718, filed Mar. 1, 1999, now U.S. Pat. No. 6,696,091 which claims priority from U.S. provisional application Ser. No. 60/076,770, filed Mar. 4, 1998, the contents of which are hereby incorporated by reference.
